Rentschler Biopharma is a leading global CDMO focused exclusively on biopharmaceuticals, with over 50 years of industry experience. The company contributed to nearly 25% of FDA-approved biopharmaceuticals in 2023, has supported 180+ biotherapeutics, and serves 180+ clients worldwide. It is an independent family-owned company employing approximately 1,400 people.
biopharmaceutical manufacturing, complex molecule development, bioprocess development, GMP biologics manufacturing, clinical and commercial supply
2 sites worldwide
No reviews available yet.
No documents available.